Acumen Pharmaceuticals, Inc. (ABOS) Misses Q3 EPS by 14c

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q3 EPS of ($0.50), $0.14 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UDynamics files for Nasdaq IPO of 5.6 million shares at $5-$7 per share
• Is the global equity rally broadening? UBS weighs in